Cases & Investigations
Berger Montague is representing proposed classes of California and New York employers who participated in Applied Underwriters Inc.’s EquityComp or SolutionOne workers compensation insurance at any time between January 1, 2006 and the present.
Berger Montague, as co-lead counsel in the securities actions, obtained a cash settlement of $80 million on behalf of investors against Xcel Energy and certain of its officers and directors.
Berger Montague represents a proposed class of direct purchasers of the drug Zetia (ezetimibe). Plaintiffs allege that Merck & Co. Inc., Merck Sharp & Dohme Corp., Schering-Plough Corp., Schering Corp., MSP Singapore Co. LLC (collectively, “Merck”), Glenmark Pharmaceuticals LTD, and Glenmark Generics Inc. (together, “Glenmark”) entered into a reverse payment agreement that delayed generic competition to Merck’s brand cholesterol drug Zetia.